Susquehanna International Group’s Oncobiologics, Inc. Series B Warrant ONSIZ Stock Holding History

Susquehanna International Group’s Portfolio ONSIZ Stock Details ONSIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-15,603	Closed	-$1K	–	10959
2018 Q1	$1K	Buy	+15,603	New	+$613	﹤0.01%	9215

Susquehanna International Group's ONSIZ Position: Q2 2018 in Review

Susquehanna International Group sold out of Oncobiologics, Inc. Series B Warrant (ONSIZ) in Q2 2018, closing a stake of 15,603 shares — an estimated $1K sold.

Susquehanna International Group first reported a position in ONSIZ in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 0 funds tracked by Wall St. Rank hold ONSIZ as of Q2 2018.

Susquehanna International Group reported no remaining Oncobiologics, Inc. Series B Warrant position as of Q2 2018 after selling out during the quarter.
Susquehanna International Group sold 15,603 Oncobiologics, Inc. Series B Warrant shares in Q2 2018, an estimated $1K.
Susquehanna International Group first reported a position in Oncobiologics, Inc. Series B Warrant in Q1 2018 and held it in 1 quarter.
Susquehanna International Group's Oncobiologics, Inc. Series B Warrant position peaked at $1K in Q1 2018.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series B Warrant as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.